Literature DB >> 9113485

A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus.

A E Gold1, B M Frier, K M MacLeod, I J Deary.   

Abstract

There are several predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus (IDDM), many of which are correlated. To assess factors which may be predictive of severe hypoglycaemia, structural equation modelling was used to test specific hypotheses using prospective data. Sixty patients with insulin-dependent diabetes mellitus (IDDM) were studied prospectively for one year during which any episodes of severe hypoglycaemia, asymptomatic biochemical hypoglycaemia, and glycaemic control were documented. Half the patients reported hypoglycaemia unawareness and they were matched for HbA1 with the rest. Baseline measurements included symptomatic awareness of hypoglycaemia, fear of hypoglycaemia, previous history of hypoglycaemia, glycaemic control, and peripheral autonomic function. Formal structural equation modelling was performed on these variables and a model was constructed that expressed the putative causal associations among the variables. The frequency of severe hypoglycaemia (measured prospectively) correlated significantly with duration of diabetes, awareness of hypoglycaemia, patient's age, history of previous severe hypoglycaemia and autonomic function scores. HbA1 did not show significant correlation, possibly because of the narrow range in the subject population. In the structural equation modelling exercise, at least 18% of the variance of severe hypoglycaemia, measured prospectively, was accounted for by a history of severe hypoglycaemia, the state of awareness of hypoglycaemia, and the autonomic function score. Over 25% of the variance of 'worry' on the hypoglycaemia fear scale was accounted for by a history of previous severe hypoglycaemia. An assessment of multiple risk factors for hypoglycaemia may be of value in advising individual patients about their diabetes care.

Entities:  

Mesh:

Year:  1997        PMID: 9113485     DOI: 10.1002/(SICI)1096-9136(199704)14:4<309::AID-DIA345>3.0.CO;2-#

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

1.  Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans.

Authors:  Kerstin M Oltmanns; Eva Deininger; Peter Wellhoener; Bernd Schultes; Werner Kern; Esther Marx; Peter Dominiak; Jan Born; Horst L Fehm; Achim Peters
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

2.  Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents.

Authors:  Linda Gonder-Frederick; Maren Nyer; Jaclyn A Shepard; Karen Vajda; William Clarke
Journal:  Diabetes Manag (Lond)       Date:  2011

Review 3.  Glycemic Variability: Risk Factors, Assessment, and Control.

Authors:  Boris Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2019-01-29

4.  Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany.

Authors:  Hartmut Schachinger; Karin Hegar; Norbert Hermanns; Madeleine Straumann; Ulrich Keller; Gabriele Fehm-Wolfsdorf; Willi Berger; Daniel Cox
Journal:  J Behav Med       Date:  2005-10-13

Review 5.  Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Authors:  Boris P Kovatchev
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

6.  Linear quadratic gaussian-based closed-loop control of type 1 diabetes.

Authors:  Stephen D Patek; Marc D Breton; Yuanda Chen; Chad Solomon; Boris Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2007-11

Review 7.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

8.  Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset.

Authors:  Rosanna Fiallo-Scharer; Jing Cheng; Roy W Beck; Bruce A Buckingham; H Peter Chase; Craig Kollman; Lori Laffel; Jean M Lawrence; Nelly Mauras; William V Tamborlane; Darrell M Wilson; Howard Wolpert
Journal:  Diabetes Care       Date:  2011-01-25       Impact factor: 19.112

Review 9.  Epidemiology of adverse drug reactions in the elderly by drug class.

Authors:  R J Beyth; R I Shorr
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 4.271

Review 10.  Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.

Authors:  Boris P Kovatchev
Journal:  Scientifica (Cairo)       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.